In this section, you will find guidelines and links to
publications about Alzheimer’s disease.
Clinical Diagnosis of Alzheimer's Disease: Recommendations of the International Working Group.19 Dubois B et al. (2021)
Be He@lthy, Be Mobile: A Handbook on How to Implement mDementia.6 World Health Organization and International Telecommunication Union (2021)
Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021.16
Porsteinsson AP et al. (2021)
Estimating Progression Rates Across the Spectrum of Alzheimer's Disease for Amyloid-Positive Individuals Using National Alzheimer's Coordinating Center Data.18 Potashman M et al. (2021)
Dementia Risk Communication. A User Manual for Brain Health Services-part 3 of 6.17
Visser LNC et al. (2021)
Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management.7 Galvin JE et al. (2021)
Risk Reduction of Cognitive Decline and Dementia. WHO - Guidelines.4 World Health Organization (2019)
Toward a Sequential Strategy for Diagnosing Neurocognitive Disorders: A Consensus from the "Act On Dementia" European Joint Action.2 Krolak-Salmon P et al. (2019)
Using Informant and Performance Screening
Methods to Detect Mild Cognitive Impairment and Dementia.3 Galvin JE (2018)
Harmonized Diagnostic Criteria for Alzheimer’s Disease: Recommendations.1 Morris JC et al. (2014)
EFNS guidelines for the Diagnosis and Management of Alzheimer’s Disease.5 Hort J et al. (2010)
ADvance is a medical education program for healthcare professionals involved in the diagnosis and care of patients with Alzheimer’s disease. It is self-paced, interactive and includes case studies shared by practitioners.
In this section, you will find practical resources to support the journey of patients
affected by AD as well as their care partners. You may want to make these materials
available at your practice.
Other valuable resources to engage and support patients
living with AD and their care partners are available through
international patient association sites such as:
1.Morris JC, Blennow K, Froelich L, et al. Harmonized diagnostic criteria for Alzheimer’s disease: recommendations. J Intern Med. 2014;275(3):204-213.
2.Krolak-Salmon P, Maillet A, Vanacore N, et al. Toward a Sequential Strategy for Diagnosing Neurocognitive Disorders: A Consensus from the "Act On Dementia" European Joint Action. J Alzheimers Dis. 2019;72(2):363-372.
3.Galvin JE. Using Informant and Performance Screening Methods to Detect Mild Cognitive Impairment and Dementia. Curr Geriatr Rep. 2018;7(1):19-25.
4.Risk reduction of cognitive decline and dementia. WHO Guidelines. Available at: pubmed.ncbi.nlm.nih.gov/31219687. Accessed January, 2022.
5.Hort J, O'Brien JT, Gainotti G, et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol. 2010;17(10):1236-1248.
6.Be He@lthy, Be Mobile: a handbook on how to implement mDementia. Geneva: World Health Organization and International Telecommunication Union, 2021. Available at: https://apps.who.int/iris/bitstream/handle/10665/339846/9789240019966-eng.pdf.
7.Galvin JE, Aisen P, Langbaum JB, et al. Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management. Front Neurol. 2021;11:592302.
8.Alzheimer Europe. www.alzheimer-europe.org. Accessed January, 2022.
9.Alzheimer’s Disease International. www.alzint.org. Accessed January, 2022.
10.Alzheimers.gov. www.alzheimers.gov. Accessed January, 2022.
11.Alzheimer’s Association. www.alz.org. Accessed January, 2022.
12.World Health Organization. Regional Office for Europe. Healthy ageing. www.euro.who.int/en/health-topics/Life-stages/healthy-ageing. Accessed January, 2022.
13.World Health Organization. Dementia. www.who.int/health-topics/dementia#tab=tab_1. Accessed January, 2022.
14.National Institute on Aging. www.nia.nih.gov/health/alzheimers. Accessed January, 2022.
15.Innovative Medicines Initiative. Project Factsheets. www.imi.europa.eu/projects-results/project-factsheets. Accessed January, 2022.
16.Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I. Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021. J Prev Alzheimers Dis. 2021.
17.Visser LNC, Minguillon C, Sánchez-Benavides G, et al. Dementia risk communication. A user manual for Brain Health Services-part 3 of 6. Alzheimers Res Ther. 2021;13(1):170.
18.Potashman M, Buessing M, Levitchi Benea M, et al. Estimating Progression Rates Across the Spectrum of Alzheimer's Disease for Amyloid-Positive Individuals Using National Alzheimer's Coordinating Center Data. Neurol Ther. 2021;10(2):941-953.
19.Dubois B, Villain N, Frisoni GB, et al. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. Lancet Neurol. 2021;20(6):484-496.